PERSPECTIVES
FULL LIST
-
The Race to Automate Cell Manufacturing
Why Cellular Manufacturing Matters Cell therapy has reached a defining moment. After two decades of breakthroughs in immunotherapy and regenerative medicine, the science has outpaced the infrastructure needed to deliver it. Each dose of a cell therapy—whether it’s a CAR-T for leukemia or an iPSC-derived tissue for Parkinson’s—requires the precise manipulation of living cells, often…
-
Using In Situ Bioprinting to Enhance Regenerative Cell Therapy
Regenerative cell therapy aims to repair or replace damaged tissues using living cells. However, traditional methods for delivering these therapeutic cells—like injecting them directly into a patient—often face challenges. Issues like cell survival, retention in the targeted area, and integration with existing tissues limit the effectiveness of these therapies. Biofabrication techniques are emerging to address…
-
Bioprinting Breast – enhancing or replacing the dominant silicone empire
A great place to a apply personalization from macro architecture is breast implants for women who have had to receive a mastectomy. Breast cancer is a growing challenge in the world as it is the most common cancer among women globally, with about 2.3 million new cases diagnosed in 2020, according to the World Health…
-
Bioprinting Ears – The pursuit to cure microtia
Intro The ear has probably been the symbol, the face, of tissue engineering and particularly bioprinting for many years. Consider the famous Vacanti ear back in 1996 that captured audiences around the world in both exciting and stomach wrenching ways. Atala then in 2016 followed with his own 3D bioprinted version that yet again captivated…
-
Bioprinting Bone – The race to control Hydroxyapatite and β-TCP
As we think about where bioprinting can truly start playing a role in implants, we naturally ask, “which tissue type will we first see become implanted?” While skin, might have been the choice we thought of about 15 years ago, as history as played out, bone is actually at the forefront of the industry. We…
-
Building Bioprinting Off Design Blocks that Have Come Before
A dynamic that is of interest to all of us is the ability to accelerate the integration and adoption of bioprinting into our healthcare workflows. We’ve seen with companies like Dimension Inx, or Cerhum who are making progress in the industry. They have been using chemistries that have come before and been approved by the…
-
The barrier to overcome cellular bioprinted products…the operational efficiency of handling cells
Intro One idea discussed, was the need for stepwise continuums to find success in bioprinted innovation. This would be where many advancements can find fruition, and also where most funding investors would find comfort given the investment time horizons are within the 10-year window or less. This is particularly relevant with medical device implants. There…
-
The stepwise continuum to bioprinted medical device innovation
The historical overpromise of bioprinting For many years, the media and the public have enjoyed to speculate on the possibilities of making implantable organs. This has been particularly driven by certain showings in the media. While good to show dreams, sometimes have given to much promise to soon. For those in the industry, we can…
-
The way to make money in pharma with bioprinting?…Develop the drugs
The Challenge A big question for 3D bioprinting is in what avenues can it become more mainstream, more of an everyday technology used in a workflow? While it can certainly be found in several research labs around the world with scientists changing slight variables to create new data to publish, its value impact in direct…
-
The DM, Stratasys, 3DS Merger Saga from the view of their Bioprinting Portfolios
The recent saga over the past year has been like watching a soap opera unfold in in terms of merger and acquisition propositions made by the 3D printing players in the market to court each other to make the so called “largest 3d printing company.” There’s different angles one can take in terms of understanding…
Subscribe
Enter your email below to receive updates.
The Business of Biofabrication 